The COVID-19 pandemic has led the world to undertake the largest vaccination campaign in
human history. In record time, unprecedented scientific and governmental efforts have …

Introduction In the first months of the novel coronavirus (COVID-19) pandemic that begun in
2020, non-pharmaceutical interventions (NPIs) have been adopted worldwide. However, the …

The recent clinical success of multiple mRNA-based SARS-CoV-2 vaccines has proven the
potential of RNA formulated in lipid nanoparticles (LNPs) in humans, and products based on …

The use of modified nucleosides is an important approach to mitigate the intrinsic
immunostimulatory activity of exogenous mRNA and to increase its translation for mRNA …

Self-amplifying RNA vaccines may induce equivalent or more potent immune responses at
lower doses compared to non-replicating mRNA vaccines via amplified antigen expression …

Designing and producing an effective vaccine is the best possible way to reduce the burden
and spread of a disease. During the coronavirus disease 2019 (COVID-19) pandemic, many …

In the present research, we focus on COVID-19 vaccine hesitancy, and empirically examine
how different forms of social identity (defensive vs. secure national identity and identification …

More than eight billion doses of COVID-19 vaccines have been administered globally so far
and 44.29% of people are fully vaccinated. Pre-authorization clinical trials were carried out …

Alphavirus vectors based on self-amplifying RNA (saRNA) generate high and transient
levels of transgene expression and induce innate immune responses, making them an …

The use of nanobubbles (NBs) for ultrasound-mediated gene therapy has recently attracted
much attention. However, few studies have evaluated the effect of different NB size …